Literature DB >> 30802639

Mutant huntingtin inhibits the mitochondrial unfolded protein response by impairing ABCB10 mRNA stability.

Zixing Fu1, Fang Liu2, Chunyue Liu1, Beifang Jin2, Yueqing Jiang1, Mingliang Tang3, Xin Qi4, Xing Guo5.   

Abstract

Numerous studies have shown that mitochondrial dysfunction contributes to consequential phenotypes of Huntington's disease (HD), a fatal and inherited neurodegenerative disease caused by the expanded CAG repeats in the N-terminus of the huntingtin (Htt) gene. To maintain proper function, mitochondria develop a dedicated protein quality control mechanism by activating a stress response termed the mitochondrial unfolded protein response (UPRmt). Defects in the UPRmt have been linked to aging and are also associated with neurodegenerative diseases. However, little is known about the role of the UPRmt in HD. In this study, we find that ABCB10, a mitochondrial transporter involved in the UPRmt pathway, is downregulated in HD mouse striatal cells, HD patient fibroblasts, and HD R6/2 mice. Deletion of ABCB10 causes increased mitochondrial reactive oxygen species (ROS) production and cell death, whereas overexpression of ABCB10 reduces these aberrant events. Moreover, the mitochondrial chaperone HSP60 and mitochondrial protease Clpp, two well-established markers of the UPRmt, are reduced in the in vitro ABCB10-deficienct HD models. CHOP, a key transcription factor of HSP60 and Clpp, is regulated by ABCB10 in HD mouse striatal cells. Furthermore, we find that mutant huntingtin (mtHtt) inhibits the mtUPR by impairing ABCB10 mRNA stability. These findings demonstrate a suppression of the UPRmt by mtHtt, suggesting that disturbance of mitochondrial protein quality control may contribute to the pathogenesis of HD.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABCB10; Huntington's disease; Mitochondrial dysfunction; Mitochondrial unfolded protein response

Mesh:

Substances:

Year:  2019        PMID: 30802639      PMCID: PMC6502650          DOI: 10.1016/j.bbadis.2019.02.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  49 in total

1.  Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

Authors:  F C Nucifora ; M Sasaki; M F Peters; H Huang; J K Cooper; M Yamada; H Takahashi; S Tsuji; J Troncoso; V L Dawson; T M Dawson; C A Ross
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

2.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  ABC-me: a novel mitochondrial transporter induced by GATA-1 during erythroid differentiation.

Authors:  O S Shirihai; T Gregory; C Yu; S H Orkin; M J Weiss
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 4.  Shaping the role of mitochondria in the pathogenesis of Huntington's disease.

Authors:  Veronica Costa; Luca Scorrano
Journal:  EMBO J       Date:  2012-03-23       Impact factor: 11.598

5.  VCP cooperates with UBXD1 to degrade mitochondrial outer membrane protein MCL1 in model of Huntington's disease.

Authors:  Xing Guo; Xin Qi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-11-29       Impact factor: 5.187

6.  SirT3 regulates the mitochondrial unfolded protein response.

Authors:  Luena Papa; Doris Germain
Journal:  Mol Cell Biol       Date:  2013-12-09       Impact factor: 4.272

Review 7.  Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators.

Authors:  Bruce M Spiegelman
Journal:  Novartis Found Symp       Date:  2007

8.  Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity.

Authors:  Wenjun Song; Jin Chen; Alejandra Petrilli; Geraldine Liot; Eva Klinglmayr; Yue Zhou; Patrick Poquiz; Jonathan Tjong; Mahmoud A Pouladi; Michael R Hayden; Eliezer Masliah; Mark Ellisman; Isabelle Rouiller; Robert Schwarzenbacher; Blaise Bossy; Guy Perkins; Ella Bossy-Wetzel
Journal:  Nat Med       Date:  2011-02-20       Impact factor: 53.440

Review 9.  Mechanisms of protein toxicity in neurodegenerative diseases.

Authors:  Chang Geon Chung; Hyosang Lee; Sung Bae Lee
Journal:  Cell Mol Life Sci       Date:  2018-06-12       Impact factor: 9.261

10.  VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease.

Authors:  Xing Guo; XiaoYan Sun; Di Hu; Ya-Juan Wang; Hisashi Fujioka; Rajan Vyas; Sudha Chakrapani; Amit Umesh Joshi; Yu Luo; Daria Mochly-Rosen; Xin Qi
Journal:  Nat Commun       Date:  2016-08-26       Impact factor: 14.919

View more
  8 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

Review 2.  The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.

Authors:  Margrethe A Olesen; Francisca Villavicencio-Tejo; Rodrigo A Quintanilla
Journal:  Transl Neurodegener       Date:  2022-07-04       Impact factor: 9.883

Review 3.  Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?

Authors:  Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Marta Talaverón-Rey; Alejandra Suárez-Carrillo; Manuel Munuera-Cabeza; Diana Reche-López; Paula Cilleros-Holgado; Rocío Piñero-Pérez; José A Sánchez-Alcázar
Journal:  Biomedicines       Date:  2022-07-06

Review 4.  Mitochondrial function in development and disease.

Authors:  Marlies P Rossmann; Sonia M Dubois; Suneet Agarwal; Leonard I Zon
Journal:  Dis Model Mech       Date:  2021-06-11       Impact factor: 5.758

5.  UPRmt activation protects against MPP+-induced toxicity in a cell culture model of Parkinson's disease.

Authors:  Di Hu; Zunren Liu; Xin Qi
Journal:  Biochem Biophys Res Commun       Date:  2021-06-30       Impact factor: 3.322

Review 6.  The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases.

Authors:  Wioletta Rozpędek-Kamińska; Natalia Siwecka; Adam Wawrzynkiewicz; Radosław Wojtczak; Dariusz Pytel; J Alan Diehl; Ireneusz Majsterek
Journal:  Int J Mol Sci       Date:  2020-03-19       Impact factor: 5.923

7.  SIRT3 Regulation of Mitochondrial Quality Control in Neurodegenerative Diseases.

Authors:  Hao Meng; Wan-Yu Yan; Yu-Hong Lei; Zheng Wan; Ye-Ye Hou; Lian-Kun Sun; Jue-Pu Zhou
Journal:  Front Aging Neurosci       Date:  2019-11-12       Impact factor: 5.750

8.  The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice.

Authors:  Brígida R Pinho; Ana I Duarte; Paula M Canas; Paula I Moreira; Michael P Murphy; Jorge M A Oliveira
Journal:  Free Radic Biol Med       Date:  2019-11-18       Impact factor: 7.376

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.